Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Hematopoietic stem cell transplantation with alpha/beta T-lymphocyte depletion and short course of eculizumab in adolescents and young adults with paroxysmal nocturnal hemoglobinuria.

Shasheleva DA, Maschan AA, Shelikhova LN, Petrova UN, Kurnikova EE, Illarionova OI, Boyakova EV, Novichkova GA, Maschan MA.

Ter Arkh. 2018 Aug 17;90(7):57-64. doi: 10.26442/terarkh201890757-64.

PMID:
30701923
2.

The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia: literature review and own experience.

Dyakonova YY, Bydanov OI, Popov AM, Olshanskaya YV, Boichenko EG, Aleynikova OV, Maschan MA, Shelikhova LN, Litvinov DV, Khachatryan LA, Ponomareva NI, Fechina LG, Novichkova GA, Pashanov ED, Karachunskiy AI.

Ter Arkh. 2018 Aug 17;90(7):38-50. doi: 10.26442/terarkh201890738-50. Review.

PMID:
30701921
3.

Molecular Approaches to Safe and Controlled Engineered T-cell Therapy.

Kalinin RS, Petukhov AV, Knorre VD, Maschan MA, Stepanov AV, Gabibov AG.

Acta Naturae. 2018 Apr-Jun;10(2):16-23.

4.

Prospective Study of a Cohort of Russian Nijmegen Breakage Syndrome Patients Demonstrating Predictive Value of Low Kappa-Deleting Recombination Excision Circle (KREC) Numbers and Beneficial Effect of Hematopoietic Stem Cell Transplantation (HSCT).

Deripapa E, Balashov D, Rodina Y, Laberko A, Myakova N, Davydova NV, Gordukova MA, Abramov DS, Pay GV, Shelikhova L, Prodeus AP, Maschan MA, Maschan AA, Shcherbina A.

Front Immunol. 2017 Jul 24;8:807. doi: 10.3389/fimmu.2017.00807. eCollection 2017.

5.

[Use of crizotinib for refractory ALK-positive lymphomas].

Shelikhova LN, Fominykh VV, Abramov DS, Myakova NV, Maschan MA, Maschan AA.

Ter Arkh. 2017;89(7):51-56. doi: 10.17116/terarkh201789751-56. Russian.

PMID:
28766541
6.

Tracking T-cell immune reconstitution after TCRαβ/CD19-depleted hematopoietic cells transplantation in children.

Zvyagin IV, Mamedov IZ, Tatarinova OV, Komech EA, Kurnikova EE, Boyakova EV, Brilliantova V, Shelikhova LN, Balashov DN, Shugay M, Sycheva AL, Kasatskaya SA, Lebedev YB, Maschan AA, Maschan MA, Chudakov DM.

Leukemia. 2017 May;31(5):1145-1153. doi: 10.1038/leu.2016.321. Epub 2016 Nov 4.

PMID:
27811849
7.

Reliability of immune receptor rearrangements as genetic markers for minimal residual disease monitoring.

Nazarov VI, Minervina AA, Komkov AY, Pogorelyy MV, Maschan MA, Olshanskaya YV, Zvyagin IV, Chudakov DM, Lebedev YB, Mamedov IZ.

Bone Marrow Transplant. 2016 Oct;51(10):1408-1410. doi: 10.1038/bmt.2016.148. Epub 2016 May 23. No abstract available.

PMID:
27214078
8.

Clinical and genomic heterogeneity of Diamond Blackfan anemia in the Russian Federation.

Smetanina NS, Mersiyanova IV, Kurnikova MA, Ovsyannikova GS, Hachatryan LA, Bobrynina VO, Maschan MA, Novichkova GA, Lipton JM, Maschan AA.

Pediatr Blood Cancer. 2015 Sep;62(9):1597-600. doi: 10.1002/pbc.25534. Epub 2015 May 6.

9.

Efficacy of plerixafor in children with malignant tumors failing to mobilize a sufficient number of hematopoietic progenitors with G-CSF.

Maschan AA, Balashov DN, Kurnikova EE, Trakhtman PE, Boyakova EV, Skorobogatova EV, Novichkova GA, Maschan MA.

Bone Marrow Transplant. 2015 Aug;50(8):1089-91. doi: 10.1038/bmt.2015.71. Epub 2015 Apr 27.

PMID:
25915808
10.

[The functional analysis of polymorphic insertions of Alu retroelements at acute lymphoblastic leukemia].

Komkov AIu, Maschan MA, Shvets VI, Lebedev IuB.

Bioorg Khim. 2012 May-Jun;38(3):351-64. Russian.

PMID:
22997707
11.

Development of T-cell acute lymphoblastic leukemia in a patient in very long lasting complete remission of juvenile myelomonocytic leukemia.

Maschan AA, Khachatrian LA, Solopova GG, Ossipova EY, Baidun LV, Dmitrieva SV, Maschan MA, Resnik IB.

J Pediatr Hematol Oncol. 2011 Jan;33(1):e32-4. doi: 10.1097/MPH.0b013e3181f46e3e.

PMID:
21102353
12.

[Transplantation of the bone marrow from a HLA-compatible unrelated donor after immunoablative conditioning in children with acquired aplastic anemia unresponsive to combined immunosuppressive therapy: preliminary results].

Novichkova GA, Maschan MA, Shipitsyna IP, Skvortsova IuV, Persiantseva MI, Lebedeva LL, Bobrynina VO, Baĭdil'dina DD, Goronkova OV, Solopova GG, Khachatrian LA, Petrova UN, Suntsova EV, Kalinina II, Sinitsyna VV, Skorobogatova EV, Balashov DN, Dyshlevaia ZM, Shelikhova LN, Kurnikova EE, Trakhtman PE, Maschan AA.

Ter Arkh. 2010;82(7):41-7. Russian.

PMID:
20853608
13.

[Results of hematopoietic cell transplantation in the first complete remission in children with acute myeloid leukemia from an intermediate risk group].

SDyshlevaia ZM, Skorobogatova EV, Maschan MA, Shipitsyna IP, Skvortsova IuV, Trakhtman PE, Balashov DN, Pashko IuV, Kurnikova EE, Suntsova EV, Goronkova OV, Solopova GG, Baĭdil'dina DD, Kalinina II, Khachatrian LA, Shneĭder MM, Maschan AA.

Ter Arkh. 2010;82(7):34-40. Russian.

PMID:
20853607
14.

[Recurrences of acute promyelocytic leukemia in children: experience with arsenic trioxide therapy and autologous hematopoietic cell transplantation].

Baĭdil'dina DD, Maschan MA, Skorobogatova EV, Dubrovina ME, Rumiantseva IuV, Maschan AA, Rumiantsev AG, Samochatova EV.

Ter Arkh. 2010;82(7):20-5. Russian.

PMID:
20853604
15.

[Clinico-laboratory variants of the course and results of therapy of hepatitis-associated aplastic anemias in children].

Novichkova GA, Maschan MA, Kravchenko EG, Baĭdil'dina DD, Bogacheva NIu, Goronkova OV, Zharikova LI, Litvinov DV, Solopova GG, Suntsova EV, Shneĭder MM, Khachatrian LA, Skorobogatova EV, Shipitsyna IP, Trakhtman PE, Balashov DN, Maschan AA.

Ter Arkh. 2007;79(7):57-61. Russian.

PMID:
17802792

Supplemental Content

Loading ...
Support Center